dapsone has been researched along with Vasospasm, Intracranial in 1 studies
Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, the authors sought to define the differences in the incidence of delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated with placebo." | 9.51 | Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial. ( Balcázar-Padrón, JC; Díaz-Ruíz, A; García-Pastor, C; Nathal, E; Navarro-Garcia de Llano, JP; Rios, C; Rodríguez-Hernandez, LA; Tristán-López, L, 2022) |
| "In this study, the authors sought to define the differences in the incidence of delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated with placebo." | 5.51 | Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial. ( Balcázar-Padrón, JC; Díaz-Ruíz, A; García-Pastor, C; Nathal, E; Navarro-Garcia de Llano, JP; Rios, C; Rodríguez-Hernandez, LA; Tristán-López, L, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Pastor, C | 1 |
| Navarro-Garcia de Llano, JP | 1 |
| Balcázar-Padrón, JC | 1 |
| Tristán-López, L | 1 |
| Rios, C | 1 |
| Díaz-Ruíz, A | 1 |
| Rodríguez-Hernandez, LA | 1 |
| Nathal, E | 1 |
1 trial available for dapsone and Vasospasm, Intracranial
| Article | Year |
|---|---|
Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Brain Ischemia; Dapsone; Female; Humans; Male; Middle Aged; Neuroprotective | 2022 |